<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Diagnosis and classification of aggressive mature B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> with atypical <z:mp ids='MP_0000002'>morphology</z:mp> remains a challenge </plain></SENT>
<SENT sid="1" pm="."><plain>To identify factors that may contribute to the atypical <z:mp ids='MP_0000002'>morphology</z:mp>, we selected eight such cases and evaluated their morphologic, immunophenotypic and cytogenetic features and clinical outcomes </plain></SENT>
<SENT sid="2" pm="."><plain>The neoplastic cells showed a diffuse monotonous infiltrating pattern with a spectrum of <z:mp ids='MP_0000002'>morphology</z:mp> including: 1) L1 lymphoblastic; 2) <z:e sem="disease" ids="C1516391" disease_type="Neoplastic Process" abbrv="">centroblastic</z:e>; 3) <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e>; and 4) mixed <z:e sem="disease" ids="C1516391" disease_type="Neoplastic Process" abbrv="">centroblastic</z:e> and <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells in most cases were positive for CD10 and/or BCL6, and showed BCL2 expression </plain></SENT>
<SENT sid="4" pm="."><plain>6 of 8 cases showed C-MYC rearrangements, and interestingly, <z:hpo ids='HP_0000001'>all</z:hpo> 6 cases demonstrated a proliferation index of &lt; or =90% </plain></SENT>
<SENT sid="5" pm="."><plain>3 of the 6 cases also demonstrated t(14;18) </plain></SENT>
<SENT sid="6" pm="."><plain>Clinical follow-up indicated that aggressive mature B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> may benefit from more intensified chemotherapeutic regimens used for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Our study suggests that aggressive mature B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> with atypical <z:mp ids='MP_0000002'>morphology</z:mp> may be another "grey zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo>" lying in the spectrum between Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
</text></document>